R&D News | pharmaphorum

News

PureTech to research Alzheimer's drugs based on 'brain drain...

US biotech PureTech Health is to develop therapies that are based on a new theory that neurological diseases such as Alzheimer’s are linked to drainage issues in the brain.

News

All eyes on Biogen and Eisai's potential Alzheimer's breakth...

Biogen and Eisai are working together on an Alzheimer’s disease treatment, and despite a

News

ViiV prepares another two-drug HIV filing

ViiV Healthcare says it is on course to change standard care in HIV treatment by providing another combination cutting the number of drugs taken to suppress the disease from three to two, f

News

Chinese pharma contaminated with scandals

Another batch of vaccines have been found “substandard”, just days after the second-largest pharmaceutical company in China admitted to falsifying test results and producing hundreds of tho

News

Diabetes - diagnosis written on a white piece of paper. Syringe and vaccine with drugs.

Type 2 diabetes research: fewer side effects from modified m...

Scientists have made progress in the quest to find medication for Type 2 diabetes that causes fewer side effects than current treatments.

News

Tafenoquine - single shot malaria cure endorsed by the FDA a...

The US Food and Drugs Administration Advisory Committee has endorsed tafenoquine, a single-dose drug from the GSK pipeline that targets one of the most frequent and widely distributed malar

PureTech to research Alzheimer's drugs based on 'brain drain...

All eyes on Biogen and Eisai's potential Alzheimer's breakth...

ViiV prepares another two-drug HIV filing

Chinese pharma contaminated with scandals

Type 2 diabetes research: fewer side effects from modified m...

Tafenoquine - single shot malaria cure endorsed by the FDA a...

Bavarian Nordic has found its new CEO

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks